Skip to Content

SEC Filings

Filing date	Form	Description	View
Nov 05, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-286284.pdf 0001193125-20-286284.rtf 0001193125-20-286284.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 04, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-20-050520.pdf 0001564590-20-050520.rtf 0001564590-20-050520.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 17, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-022561.pdf 0000899243-20-022561.rtf 0000899243-20-022561.xls View HTML
Aug 17, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-022559.pdf 0000899243-20-022559.rtf 0000899243-20-022559.xls View HTML
Aug 13, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-022283.pdf 0000899243-20-022283.rtf 0000899243-20-022283.xls View HTML
Aug 13, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-022284.pdf 0000899243-20-022284.rtf 0000899243-20-022284.xls View HTML
Aug 07, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-20-038076.pdf 0001564590-20-038076.rtf 0001564590-20-038076.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 07, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-212544.pdf 0001193125-20-212544.rtf 0001193125-20-212544.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 03, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-021047.pdf 0000899243-20-021047.rtf 0000899243-20-021047.xls View HTML
Aug 03, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-021044.pdf 0000899243-20-021044.rtf 0000899243-20-021044.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2022 Merrimack Pharmaceuticals.